JENBURKT PHARMACEUTICALS
Back to Income Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Sales | ₹152 Cr | ₹142 Cr | ₹137 Cr | ₹124 Cr | ₹109 Cr |
What is the latest Revenue of JENBURKT PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2025 | ₹152 Cr |
Mar2024 | ₹142 Cr |
Mar2023 | ₹137 Cr |
Mar2022 | ₹124 Cr |
Mar2021 | ₹109 Cr |
How is Revenue of JENBURKT PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2025 | ₹152 Cr | 6.85 | |
Mar2024 | ₹142 Cr | 3.82 | |
Mar2023 | ₹137 Cr | 10.30 | |
Mar2022 | ₹124 Cr | 13.44 | |
Mar2021 | ₹109 Cr | - |
Compare Revenue of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹584.5 Cr | -2.7% | 0.7% | 50% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | -2.7% |
0.7% |
50% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses